Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
27%
OVERLAP
BY WEIGHT
36
# OF OVERLAPPING
HOLDINGS
BMED
137
HOLDINGS
32%
ALSO IN WDNA
WDNA
85
HOLDINGS
46%
ALSO IN BMED
SECTOR DRIFT (BMED minus WDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 3.3% | 2.7% | 2.7% |
|
NATERA INC | 2.1% | 2.9% | 2.1% |
|
GILEAD SCIENCES INC | 2.7% | 1.7% | 1.7% |
|
AMGEN INC | 1.6% | 2.2% | 1.6% |
|
EXACT SCIENCES CORP | 3.0% | 1.6% | 1.6% |
BMED Overweight Relative to WDNA
 |
ROCHE HOLDING AG-BR | 3.4% |
 |
MEDTRONIC PLC | 3.2% |
|
EDWARDS LIFESCIENCES CORP | 2.6% |
|
GUARDANT HEALTH, INC. | 2.5% |
|
ABBOTT LABORATORIES | 2.0% |
|
MERCK & CO. INC. | 1.9% |
|
INSULET CORP | 1.9% |
|
AGILENT TECHNOLOGIES INC | 1.9% |
 |
GENMAB A/S | 1.8% |
 |
SARTORIUS AG PREF | 1.5% |
BMED Underweight Relative to WDNA
|
ELI LILLY & CO | -3.1% |
|
UNITED THERAPEUTICS CORP | -2.3% |
|
AMICUS THERAPEUTICS INC | -2.2% |
|
REGENXBIO, INC. | -2.2% |
|
NOVO NORDISK A/S-B | -2.2% |
|
BIONTECH SE SPONSORED ADR | -2.1% |
|
CRISPR THERAPEUTICS AG | -2.1% |
|
NOVOZYMES A/S-B SHARES | -2.0% |
|
STOKE THERAPEUTICS, INC. | -2.0% |
|
PFIZER INC | -2.0% |